Spire Healthcare Group Plc

Spire Healthcare Group Plc

SPI · LSE · Healthcare / Medical Care Facilities

247.50GBX+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close247.50
Open247.50
Day Range247.50 – 248.50
52-Week Range139.84 – 248.00
Volume691.11K
Market Cap991.48M
P/E (TTM)0.00
Forward P/E12.97
EPS0.00
Dividend Yield0.61%
Beta0.88
50-Day Avg238.94
200-Day Avg202.75

About

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. It also offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, digestive and bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. In addition, the company provides eye surgery and treatments, family planning, gastroenterology, general medicine, haematology, hand surgery, hip and knee replacement treatment, and heart and kidney treatments. Further, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal neurosurgery, sports science, urology, vascular surgery, weight loss, and women's health. Additionally, the company provides treatments in the areas of breast enlargement, cataract removal surgery, gastric bypass surgery, and prostate surgery; and offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOSir David Morgan Sloman
  • Employees17.80K
  • Headquarters3 Dorset Rise, London, United Kingdom, EC4Y 8EN, UK
  • Websitehttps://www.spirehealthcare.com

Leadership

  • Sir David Morgan SlomanInterim CEO & Vice Chairman of the Board · b. 1961
  • Mr. Harbant Singh SamraCFO & Executive Director · b. 1979
  • Sir Ian Michael Cheshire M.A.Advisor · b. 1959
  • Prof. Lisa Jane GrantGroup Chief Nursing Officer & COO · b. 1976
  • Ms. Amie GramlickDirector of Commercial Finance & Investor Relations
  • Mr. Mantraraj Dipak BudhdevGroup General Counsel, Company Secretary & Chief People Officer · b. 1986
  • Mr. Peter CorfieldChief Commercial Officer
  • Mr. Derrick Michael FarrellChief Executive Officer of Vita Health Group
  • Dr. Catherine Mary CaleGroup Medical Director
  • Ms. Rebecca HarperGroup Corporate Affairs Director

Financials

Income Statement

Currency: GBP2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue674.00M738.90M764.50M856.00M884.80M926.40M931.70M931.10M980.80M919.90M1.11B1.20B1.36B1.51B1.58B
Growth (%)-+9.63%+3.46%+11.97%+3.36%+4.70%+0.57%-0.06%+5.34%-6.21%+20.25%+8.34%+13.39%+11.20%+4.54%
Cost of Revenue320.90M366.40M382.10M436.60M460.00M485.90M492.20M497.60M621.00M558.10M712.10M758.00M838.40M827.60M980.70M
Gross Profit353.10M372.50M382.40M419.40M424.80M440.50M439.50M433.50M359.80M361.80M394.10M440.50M520.60M683.60M599.10M
Gross Margin52.39%50.41%50.02%49.00%48.01%47.55%47.17%46.56%36.68%39.33%35.63%36.75%38.31%45.24%37.92%
Operating Expense218.90M242.70M271.30M305.30M314.40M331.80M347.50M338.10M262.30M292.80M312.90M336.30M394.10M546.10M453.00M
Operating Income134.20M129.80M111.10M114.10M110.40M108.70M92.00M95.40M97.50M69.00M81.20M104.20M126.50M137.50M146.10M
Operating Margin19.91%17.57%14.53%13.33%12.48%11.73%9.87%10.25%9.94%7.50%7.34%8.69%9.31%9.10%9.25%
EBITDA181.90M53.10M145.10M126.80M143.90M145.10M100.40M163.50M185.30M-51.90M182.20M193.30M231.20M250.40M265.70M
EBITDA Margin26.99%7.19%18.98%14.81%16.26%15.66%10.78%17.56%18.89%-5.64%16.47%16.13%17.01%16.57%16.82%
Net Income-22.30M-130.00M102.20M6.00M60.00M53.60M16.80M100.00K7.20M-233.90M-9.70M8.60M27.30M25.40M16.40M
Net Income Margin-3.31%-17.59%13.37%0.70%6.78%5.79%1.80%0.01%0.73%-25.43%-0.88%0.72%2.01%1.68%1.04%
Interest Expense175.50M183.20M154.00M88.70M21.40M20.00M20.30M80.20M84.10M85.10M87.00M91.50M93.00M98.40M105.00M
Interest Expense % of Total Revenue26.04%24.79%20.14%10.36%2.42%2.16%2.18%8.61%8.57%9.25%7.86%7.63%6.84%6.51%6.65%

Balance Sheet

Currency: GBP2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.23B2.25B1.61B1.61B1.66B1.72B1.73B2.26B2.29B2.10B2.24B2.16B2.29B2.34B2.38B
Total Liabilities2.65B2.69B1.87B651.10M659.60M689.10M696.20M1.31B1.35B1.40B1.53B1.43B1.55B1.60B1.63B
Total Equity-426.50M-441.80M-256.20M955.00M997.60M1.04B1.04B948.50M939.90M706.60M709.60M731.00M739.90M748.40M742.80M
Cash95.40M133.80M111.50M74.50M78.90M67.90M39.20M47.70M90.80M106.30M202.60M74.20M49.60M41.20M34.70M
Total Debt2.06B2.13B1.63B498.80M498.40M500.20M502.00M1.15B1.17B1.17B1.27B1.19B1.26B1.28B1.32B
Net Debt1.96B2.00B1.52B424.30M419.50M432.30M462.80M1.10B1.08B1.06B1.06B1.12B1.21B1.24B1.28B

Cash Flow

Currency: GBP2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow194.60M176.80M99.70M113.00M155.30M177.40M124.00M182.60M201.70M141.70M170.60M181.60M215.50M235.70M219.30M
Investing Cash Flow-43.30M-34.80M647.10M-70.00M-109.60M-149.90M-118.30M-68.00M-48.60M-46.40M-48.30M-95.30M-157.20M-99.00M-90.40M
Financing Cash Flow-93.90M-103.60M-769.10M-80.00M-41.30M-38.50M-34.40M-106.10M-110.00M-79.80M-26.00M-214.70M-82.90M-145.10M-135.40M
Capital Expenditure43.10M55.20M53.70M66.60M109.50M149.50M119.20M73.70M60.60M46.60M69.30M87.70M84.40M112.10M76.30M
Free Cash Flow151.50M121.60M46.00M46.40M45.80M27.90M4.80M108.90M141.10M95.10M101.30M93.90M115.50M123.60M143.00M
Dividends Paid--12.40M12.40M12.40M14.80M15.20M15.20M15.20M100.00K100.00K300.00K2.00M8.50M9.20M
FCF to OCF77.85%68.78%46.14%41.06%29.49%15.73%3.87%59.64%69.96%67.11%59.38%51.71%53.60%52.44%65.21%
Dividend Paid to FCF--26.96%26.72%27.07%53.05%316.67%13.96%10.77%0.11%0.10%0.32%1.73%6.88%6.43%

Earnings

Report DateJan 31, 2011Mar 31, 2011Jun 30, 2011Sep 30, 2011Jan 31, 2012Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Jan 31, 2013Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Jan 31, 2014Mar 31, 2014Jun 30, 2014Sep 30, 2014Jan 31, 2015Mar 24, 2015Mar 31, 2015Aug 21, 2015Sep 30, 2015Jan 31, 2016Mar 17, 2016Mar 31, 2016Aug 25, 2016Jan 31, 2017Mar 2, 2017Mar 31, 2017Sep 15, 2017Jan 31, 2018Mar 2, 2018Mar 31, 2018Sep 18, 2018Jan 31, 2019Feb 28, 2019Mar 31, 2019Sep 16, 2019Mar 5, 2020Sep 17, 2020Mar 4, 2021Sep 9, 2021Mar 3, 2022Sep 8, 2022Mar 2, 2023Sep 14, 2023Feb 29, 2024Sep 13, 2024Dec 31, 2024Jul 31, 2025Dec 31, 2025Sep 30, 2026Mar 4, 2027
EPS Estimate-------------------0.00-0.00--0.00-8.80-0.00-7.70-5.90-4.70-1.90-3.202.20--4.40-1.204.402.801.502.502.305.00-0.04---
EPS Actual-0.01-0.01-0.03-0.01-0.08-0.08-0.16-0.08-0.160.060.060.37--0.15-0.15--0.03-0.040.00-0.00-0.030.07-0.090.010.04-0.020.010.02-0.020.000.01-0.020.00-0.580.00-0.040.020.000.020.000.000.000.030.040.02--
Surprise---------------------------98.98%----99.74%--99.66%--99.57%--99.47%--99.38%-100.00%-100.00%96.67%-99.55%-100.00%-98.67%-100.00%-100.00%-100.00%--6.82%---
Timing-------------------Pre-market-Pre-market--Pre-market-Pre-market-Pre-market-Pre-market-Pre-market-Pre-market-Pre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market--After-hours-After-hoursPre-market

Key Statistics & Ratios

Market Cap991.48M
Enterprise Value2.26B
Trailing P/E0.00
Forward P/E12.97
PEG Ratio0.00
Price / Sales0.63
Price / Book1.32
EPS0.00
Book Value1.85
Revenue (TTM)1.58B
Gross Profit (TTM)712.30M
EBITDA191.70M
Profit Margin-0.12%
Operating Margin6.21%
Return on Equity-0.18%
Return on Assets3.19%
Shares Outstanding400.60M
Shares Float204.58M
Beta0.88
Dividend Yield0.61%
Dividend Rate0.02
Payout Ratio60.73%

Dividends

20261×
0.01May 21, 2026
20251×
0.02May 22, 2025
20241×
0.02May 23, 2024
20231×
0.01May 25, 2023
20201×
0.03May 28, 2020
20192×
0.01Nov 14, 20190.03May 30, 2019
20182×
0.01Nov 15, 20180.03May 31, 2018
20172×
0.01Nov 16, 20170.03Jun 1, 2017
20162×
0.01Nov 17, 20160.02Jun 2, 2016
20152×
0.01Nov 19, 20150.02Jun 4, 2015